Retatrutide helped trial participants lose up to 28.7% of their body weight, but experts warn about excessive weight loss.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Zepbound, Wegovy and other GLP-1 drugs reduce the urge to eat everything on one’s plate, but ...

In recent months, the Trump administration struck a deal with pharmaceutical companies to lower the price many Americans pay for popular drugs used for weight loss, such as Ozempic and Wegovy. As a ...

Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...

Top executives from drugmakers big and small told CNBC that the next phase of the obesity drug market will be defined by a broader range of treatment options and improved access for patients. CNBC ...